On Primary Adrenal Insufficiency with Normal Concentrations of Cortisol – Early Manifestation of Addison’s Disease

Abstract

Primary adrenal insufficiency (AI) is an endocrine disorder in which hormones of the adrenal cortex are produced to an insufficient extent. Since receptors for adrenal steroids have a wide distribution, initial symptoms may be nonspecific. In particular, the lack of glucocorticoids can quickly lead to a life-threatening adrenal crisis. Therefore, current guidelines suggest applying a low threshold for testing and to rule out AI not before serum cortisol concentrations are higher than 500 nmol/l (18 μg/dl). To ease the diagnostic, determination of morning cortisol concentrations is increasingly used for making a diagnosis whereby values of>350 nmol/l are considered to safely rule out Addison’s disease. Also, elevated corticotropin concentrations (>300 pg/ml) are indicative of primary AI when cortisol levels are below 140 nmol/l (5 μg/dl). However, approximately 10 percent of our patients with the final diagnosis of primary adrenal insufficiency would clearly have been missed for they presented with normal cortisol concentrations. Here, we present five such cases to support the view that normal to high basal concentrations of cortisol in the presence of clearly elevated corticotropin are indicative of primary adrenal insufficiency when the case history is suggestive of Addison’s disease. In all cases, treatment with hydrocortisone had been started, after which the symptoms improved. Moreover, autoantibodies to the adrenal cortex had been present and all patients underwent a structured national education program to ensure that self-monitored dose adjustments could be made as needed.

Key words

adrenal insufficiency - hyponatremia - glucocorticoid - aldosterone - adrenal crisis

Publikationsverlauf

Eingereicht: 28. Juli 2023

Angenommen nach Revision: 22. September 2023

Artikel online veröffentlicht:
02. November 2023

• References

• 1 Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003; 361: 1881-1893
• 2 Addison T. On the constitutional and local effects of disease of the suprarenal capsules. A collection of the published writings of the late Thomas Addison MD. London: New Sydenham Society. 1868
• 3 Webb EA, Krone N. Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency. Best Pract Res Clin Endocrinol Metab 2015; 29: 449-468
• 4 Charmandari E, Nicolaides NC, Chrousos GP. Adrenal insufficiency. Lancet 2014; 383: 2152-2167
• 5 Bornstein SR, Allolio B, Arlt W. et al. Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2016; 101: 364-389
• 6 Husebye ES, Allolio B, Arlt W. et al. Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 2014; 275: 104-115
• 7 Allolio B. Extensive expertise in endocrinology. Adrenal crisis. Eur J Endocrinol 2015; 172: R115-R124
• 8 Hahner S, Spinnler C, Fassnacht M. et al. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency – a prospective study. J Clin Endocrinol Metab 2015; 100: 407-416
• 9 Repping-Wuts HJ, Stikkelbroeck NM, Noordzij A. et al. A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis. Eur J Endocrinol 2013; 169: 17-22
• 10 Paschali M, Willenberg HS, Fritzen R. et al. False positives on both dexamethasone testing and urinary free cortisol in women on oral contraception: dose-response effects. Clin Endocrinol 2013; 79: 443-444
• 11 Burger-Stritt S, Eff A, Quinkler M. et al. Standardised patient education in adrenal insufficiency: a prospective multi-centre evaluation. Eur J Endocrinol 2020; 183: 119-127
• 12 Diederich S, Franzen NF, Bähr V. et al. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol 2003; 148: 609-617
• 13 Yanase T, Tajima T, Katabami T. et al. Diagnosis and treatment of adrenal insufficiency including adrenal crisis: a Japan Endocrine Society clinical practice guideline. Endocr J 2016; 63: 765-784
• 14 Reznik Y, Barat P, Bertherat J. et al. SFE/SFEDP adrenal insufficiency French consensus: introduction and handbook. Ann Endocrinol 2018; 79: 1-22
• 15 Hahner S, Ross RJ, Arlt W. et al. Adrenal insufficiency. Nat Rev Dis Primers 2021; 7: 19l
• 16 Mathara Diddhenipothage SAD, Beck KJ, Loo H. et al. A morning cortisol is the most effective clinical predictor of short synacthen test outcome: a tertiary care centre experience. Clin Endocrinol 2023; 99: 142-151
• 17 Kazlauskaite R, Evans AT, Villabona CV. et al. Consortium for evaluation of corticotropin test in hypothalamic-pituitary adrenal insufficiency. Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metab 2008; 93: 4245-4253
• 18 Hyponatraemia guideline development group. Spasovski G, Vanholder R, Allolio B. et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 2014; 170: G1-G47
• 19 Ceccato F, Torchio M, Tizianel I. et al. Renin and electrolytes indicate the mineralocorticoid activity of fludrocortisone: a 6 year study in primary adrenal insufficiency. J Endocrinol Invest 2023; 46: 111-122
• 20 Debono M, Elder CJ, Lewis J. et al. Home waking salivary cortisone to screen for adrenal insufficiency. NEJM Evid 2023; 2: 1-11
• 21 Younes N, Bourdeau I, Lacroix A. Latent adrenal insufficiency: from concept to diagnosis. Front Endocrinol 2021; 12: 720769
• 22 Raverot V, Richet C, Morel Y. et al. Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys® Cortisol II Assay. Ann Endocrinol 2016; 77: 620-622